Literature DB >> 16612349

Can super-antibody drugs be tamed?

.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16612349     DOI： 10.1038/440855a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Transient regulatory T-cells: a state attained by all activated human T-cells.

Authors:  Vinodh Pillai; Sterling B Ortega; C K Wang; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2006-12-19       Impact factor: 3.969

Review 2.  [Drug trials in humans. Risks in the light of the London catastrophe].

Authors:  A Otte
Journal:  Internist (Berl)       Date:  2007-06       Impact factor: 0.743

Review 3.  Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?

Authors:  Vinodh Pillai; Nitin J Karandikar
Journal:  Immunol Lett       Date:  2007-09-29       Impact factor: 3.685

4.  Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeutics.

Authors:  Stephen Thompson; John Dessi; Colin H Self
Journal:  MAbs       Date:  2009-07-19       Impact factor: 5.857

5.  Safety concerns on the development of novel therapeutic drugs.

Authors:  Caroline Ospelt; Steffen Gay
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 6.  Regulatory T cells and human disease.

Authors:  Nathalie Cools; Peter Ponsaerts; Viggo F I Van Tendeloo; Zwi N Berneman
Journal:  Clin Dev Immunol       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.